268 related articles for article (PubMed ID: 23437135)
1. Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.
Mugglin C; Wandeler G; Estill J; Egger M; Bender N; Davies MA; Keiser O
PLoS One; 2013; 8(2):e56446. PubMed ID: 23437135
[TBL] [Abstract][Full Text] [Related]
2. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
Mugglin C; Estill J; Wandeler G; Bender N; Egger M; Gsponer T; Keiser O;
Trop Med Int Health; 2012 Dec; 17(12):1509-20. PubMed ID: 22994151
[TBL] [Abstract][Full Text] [Related]
3. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.
Rosen S; Fox MP
PLoS Med; 2011 Jul; 8(7):e1001056. PubMed ID: 21811403
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.
; Keiser O; Anastos K; Schechter M; Balestre E; Myer L; Boulle A; Bangsberg D; Touré H; Braitstein P; Sprinz E; Nash D; Hosseinipour M; Dabis F; May M; Brinkhof MW; Egger M
Trop Med Int Health; 2008 Jul; 13(7):870-9. PubMed ID: 18373510
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.
Munthali C; Taegtmeyer M; Garner PG; Lalloo DG; Squire SB; Corbett EL; Ford N; MacPherson P
J Int AIDS Soc; 2014; 17(1):18932. PubMed ID: 24929097
[TBL] [Abstract][Full Text] [Related]
7. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
Panayidou K; Davies MA; Anderegg N; Egger M;
J Int AIDS Soc; 2018 Nov; 21(11):e25200. PubMed ID: 30614622
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
10. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.
Kranzer K; Govindasamy D; Ford N; Johnston V; Lawn SD
J Int AIDS Soc; 2012 Nov; 15(2):17383. PubMed ID: 23199799
[TBL] [Abstract][Full Text] [Related]
11. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
[TBL] [Abstract][Full Text] [Related]
12. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings--a systematic review.
Govindasamy D; Meghij J; Kebede Negussi E; Clare Baggaley R; Ford N; Kranzer K
J Int AIDS Soc; 2014; 17(1):19032. PubMed ID: 25095831
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
[TBL] [Abstract][Full Text] [Related]
14. Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
Bassett IV; Regan S; Chetty S; Giddy J; Uhler LM; Holst H; Ross D; Katz JN; Walensky RP; Freedberg KA; Losina E
AIDS; 2010 Jan; 24 Suppl 1(Suppl 1):S37-44. PubMed ID: 20023438
[TBL] [Abstract][Full Text] [Related]
15. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
Gabillard D; Lewden C; Ndoye I; Moh R; Segeral O; Tonwe-Gold B; Etard JF; Pagnaroat M; Fournier-Nicolle I; Eholié S; Konate I; Minga A; Mpoudi-Ngole E; Koulla-Shiro S; Zannou DM; Anglaret X; Laurent C;
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):555-61. PubMed ID: 23274931
[TBL] [Abstract][Full Text] [Related]
16. Barriers to antiretroviral initiation in HIV-1-discordant couples.
Guthrie BL; Choi RY; Liu AY; Mackelprang RD; Rositch AF; Bosire R; Manyara L; Gatuguta A; Kiarie JN; Farquhar C
J Acquir Immune Defic Syndr; 2011 Nov; 58(3):e87-93. PubMed ID: 21826010
[TBL] [Abstract][Full Text] [Related]
17. Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.
Anglaret X; Scott CA; Walensky RP; Ouattara E; Losina E; Moh R; Becker JE; Uhler L; Danel C; Messou E; Eholié S; Freedberg KA
Antivir Ther; 2013; 18(1):45-55. PubMed ID: 22809695
[TBL] [Abstract][Full Text] [Related]
18. Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness.
Fox MP; Rosen S; Geldsetzer P; Bärnighausen T; Negussie E; Beanland R
J Int AIDS Soc; 2016; 19(1):20888. PubMed ID: 27507249
[TBL] [Abstract][Full Text] [Related]
19. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Siegfried N; Uthman OA; Rutherford GW
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
[TBL] [Abstract][Full Text] [Related]
20. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
